Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

FT Global Pharma and Biotech Summit: Jayasree K. Iyer to speak on pricing and access

Access to Medicine Foundation CEO Jayasree K. Iyer will join a panel of global industry experts to discuss the outlook for pricing and market access as we move into 2023.

Date

08 November 2022

Date

Summit: 7–9 November

Panel discussion: Tuesday 8 November, 16:40 – 17:25 CEST

Location

London, England

Format

Hybrid – in-person & virtual

About the event 

The Global Pharma and Biotech Summit is an annual event for industry professionals to stay on top of the latest trends and innovations in life sciences. CEOs, policymakers and thought leaders from around the world will discuss what’s new in areas such as drug discovery, clinical trials and market access.  

Panel discussion

Jayasree will speak at this year’s Summit as a panelist on the topic, ‘Pricing and market access – What to expect in 2023’. 

Drawing on her expertise in engaging the pharmaceutical industry on the biggest issues in access and health – and challenging companies to work within the realities of doing business to translate principles into practices – she will join other expert panelists in answering the following:

  • How can we expect regulatory frameworks for approval to evolve in key regions?

  • What developments are likely in pricing and market access for high-cost advanced therapies?

  • What can be done to increase access and affordability in emerging markets?

  • What are the prospects for the rise of accelerated or ‘real-time’ approval for new drugs beyond the pandemic?


Find out more about the agenda and topics of the FT Global Pharma and Biotech Summit here.


Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved